CACNA1A (calcium voltage-gated channel subunit alpha1 A) Gene Mutation Analysis
The calcium voltage-gated channel subunit alpha1 A (CACNA1A) gene is located in the short (p) arm of chromosome 19 at position 13.13 encodes the pore-forming α1 subunit of the neuronal voltage-gated P/Q-type calcium channel (Cav2.1). Cav2.1 is widely expressed in the central nervous system (CNS), especially in Purkinje cells and granule cells of the cerebellum. These channels transport positively charged calcium ions across the cell membrane and generate electrical signals.
Alterations in the CACNA1A gene are associated with several different neurologic disorders. Missense mutations in CACNA1A are associated with familial hemiplegic migraine and truncating mutations are associated with episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6.
- As aid in diagnosis of Spinocerebellar Ataxia Type 6 (SCA6)
- As an aid in diagnosis of familial hemiplegic migraine
- As an aid in the diagnosis of episodic ataxia 2
- Useful in identification of family members who are at risk
Normal:
- No mutation or pathogenic variants in CACNA1A gene and no expansion on CAG repeat (4-18) in entire codon
Abnormal:
- Mutation in CACNA1A gene or pathogenic variants (small intragenic deletions/insertions and missense, nonsense, and splice site variants) and expansion of CAG repeat > 4-18
No mutation or pathogenic variants in CACNA1A gene and no expansion on CAG repeat (4-18) in entire codon
Whole blood (EDTA/lavender top tube).
Stability
- Room temperature: 5-7 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- Neurotherapeutics. 2007 Apr;4(2):285-94. [PMID: 17395139]
- F1000 Biol Rep. 2010; 2: 4. [PMID: 20948794]
- Sci Rep. 2017;7: 2514. [PMID: 28566750]
- Mol Genet Genomic Med. 2016;4: 211-22. [PMID: 27066515]
- Biochim Biophys Acta. 2014;1838: 1693-700. [PMID: 24704353]
- Front Neurol. 2011; 2:51. [PMID: 21927611]
- Pflugers Arch. 2010;460: 375-93. [PMID: 20204399]
- Neurology. 2005;64: 2090-7. [PMID: 15985579]